Atwater Malick’s Colgate-Palmolive CL Stock Holding History

Atwater Malick’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,954	Closed	-$144K	–	73
2019 Q3	$144K	Buy	+1,954	New	+$142K	0.12%	43

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atwater Malick's CL Position: Q4 2019 in Review

Atwater Malick sold out of Colgate-Palmolive (CL) in Q4 2019, closing a stake of 1,954 shares — an estimated $144K sold.

Atwater Malick first reported a position in CL in Q3 2019 and held it in 1 quarter. The position peaked at $144K in Q3 2019. 1,510 funds tracked by Wall St. Rank hold CL as of Q4 2019.

Atwater Malick reported no remaining Colgate-Palmolive position as of Q4 2019 after selling out during the quarter.
Atwater Malick sold 1,954 Colgate-Palmolive shares in Q4 2019, an estimated $144K.
Atwater Malick first reported a position in Colgate-Palmolive in Q3 2019 and held it in 1 quarter.
Atwater Malick's Colgate-Palmolive position peaked at $144K in Q3 2019.
1,510 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2019.

Based on Atwater Malick's 13F filing for Q4 2019, filed 7 Jan 2020.